Pfizer Showcases Clinical Advancements Across Infectious Diseases at IDWeek 2026
Data from 57 abstracts will highlight Pfizer's scientific progress targeting infectious diseases, including pneumococcal disease and RSV Pfizer Inc. (NYSE: PFE) will present data from more than 50 company-sponsored, investigator-sponsored and …